Insider · CIK 0002034219
David Duane House
Files at ARMP (Armata Pharmaceuticals, Inc.). First filing -, latest -.
David Duane House files SEC Form 4 as officer at ARMP (Armata Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Duane House has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +109,885 | $0.00 | $0 | 109,885 | Mar 11, 2026 |
| Feb 5, 2025 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Feb 7, 2025 |
Questions about David Duane House
Answered from the filings on this page, as of the latest one.
Is David Duane House buying or selling?
David Duane House has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Duane House's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Duane House has 0.
Where does David Duane House file Form 4?
David Duane House has filed Form 4 at ARMP (Armata Pharmaceuticals, Inc.) as SVP, Finance, and PFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.